A systematic review of trismus induced by cancer therapies in head and neck cancer patients
Purpose This systematic review represents a thorough evaluation of the literature to clarify the impact of cancer therapies on the prevalence, quality of life and economic impact, and management strategies for cancer-therapy-induced trismus. Methods A systematic literature search was conducted with...
Gespeichert in:
| Veröffentlicht in: | Supportive care in cancer 2010-08, Vol.18 (8), p.1033-1038 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1038 |
|---|---|
| container_issue | 8 |
| container_start_page | 1033 |
| container_title | Supportive care in cancer |
| container_volume | 18 |
| creator | Bensadoun, Rene-Jean Riesenbeck, Dorothea Lockhart, Peter B. Elting, Linda S. Spijkervet, Fred K. L. Brennan, Mike T. |
| description | Purpose
This systematic review represents a thorough evaluation of the literature to clarify the impact of cancer therapies on the prevalence, quality of life and economic impact, and management strategies for cancer-therapy-induced trismus.
Methods
A systematic literature search was conducted with assistance from a research librarian in the databases MEDLINE/PubMed and EMBASE for articles published between January 1, 1990 and December 31, 2008. Each study was independently assessed by two reviewers. Taking into account predetermined quality measures, a weighted prevalence was calculated for the prevalence of trismus. The level of evidence, recommendation grade, and guideline (if possible) were given for published preventive and management strategies for trismus.
Results
We reviewed a total of 22 published studies between 1990 and 2008. Most of them assessed the prevalence of this complication, and few focused on management. The weighted prevalence for trismus was 25.4% in patients who received conventional radiotherapy and 5% for the few intensity-modulated radiation therapy studies. No clear guideline recommendations could be made for the prevention or management of trismus.
Conclusions
Newer radiation modalities may decrease the prevalence of trismus compared to conventional radiotherapy. Few studies have addressed the quality of life impact of trismus, and no studies were identified to assess the economic impact of trismus. The few preventive and management trials identified in the literature showed some promise, although larger, well-designed studies are required to appropriately assess these therapies before recommendations can be provided. |
| doi_str_mv | 10.1007/s00520-010-0847-4 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_748936032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A358058244</galeid><sourcerecordid>A358058244</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-1746217b666b10304585ce2a6fd1f76e396b579e38f2763debc6554f65e72d3</originalsourceid><addsrcrecordid>eNp1kU1rFTEUhoMo9nr1B7iRoAtXU_OdmeWl-AUFF-3ORcgkJ23qncw1mancf2-GaRWl5RAO5Dzvyzm8CL2m5JQSoj8UQiQjDaH1tUI34gnaUMF5oznvnqIN6QRtBJfyBL0o5YYQqrVkz9EJI4xyxvUGfd_hciwTDHaKDme4jfALjwFPOZZhLjgmPzvwuD9iZ5ODjKdryPYQYZnha7Ae2-RxAvfjnjhUL0hTeYmeBbsv8Oqub9HFp4-XZ1-a82-fv57tzhsnCZ8aqoViVPdKqZ4SToRspQNmVfA0aAW8U73UHfA2MK24h94pKUVQEjTzfIver66HPP6coUxmiMXBfm8TjHMxWrQdV6Seu0Vv_yNvxjmnupppFelkq6iu0LsVurJ7MDGFccrWLZZmx2VLZMuEqNTpA1QtD0N0Y4IQ6_8_AroKXB5LyRDMIcfB5qOhxCxhmjVMU8M0S5hm0by523fuB_B_FPfpVYCtQKmjdAX570GPu_4GQvGmvg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>860958617</pqid></control><display><type>article</type><title>A systematic review of trismus induced by cancer therapies in head and neck cancer patients</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Bensadoun, Rene-Jean ; Riesenbeck, Dorothea ; Lockhart, Peter B. ; Elting, Linda S. ; Spijkervet, Fred K. L. ; Brennan, Mike T.</creator><creatorcontrib>Bensadoun, Rene-Jean ; Riesenbeck, Dorothea ; Lockhart, Peter B. ; Elting, Linda S. ; Spijkervet, Fred K. L. ; Brennan, Mike T. ; Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)</creatorcontrib><description>Purpose
This systematic review represents a thorough evaluation of the literature to clarify the impact of cancer therapies on the prevalence, quality of life and economic impact, and management strategies for cancer-therapy-induced trismus.
Methods
A systematic literature search was conducted with assistance from a research librarian in the databases MEDLINE/PubMed and EMBASE for articles published between January 1, 1990 and December 31, 2008. Each study was independently assessed by two reviewers. Taking into account predetermined quality measures, a weighted prevalence was calculated for the prevalence of trismus. The level of evidence, recommendation grade, and guideline (if possible) were given for published preventive and management strategies for trismus.
Results
We reviewed a total of 22 published studies between 1990 and 2008. Most of them assessed the prevalence of this complication, and few focused on management. The weighted prevalence for trismus was 25.4% in patients who received conventional radiotherapy and 5% for the few intensity-modulated radiation therapy studies. No clear guideline recommendations could be made for the prevention or management of trismus.
Conclusions
Newer radiation modalities may decrease the prevalence of trismus compared to conventional radiotherapy. Few studies have addressed the quality of life impact of trismus, and no studies were identified to assess the economic impact of trismus. The few preventive and management trials identified in the literature showed some promise, although larger, well-designed studies are required to appropriately assess these therapies before recommendations can be provided.</description><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-010-0847-4</identifier><identifier>PMID: 20213237</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Antimitotic agents ; Antineoplastic agents ; Cancer ; Cancer patients ; Care and treatment ; Chemotherapy ; Head & neck cancer ; Head and Neck Neoplasms - therapy ; Health aspects ; Humans ; Medicine ; Medicine & Public Health ; Nuclear radiation ; Nursing ; Nursing Research ; Oncology ; Pain Medicine ; Practice Guidelines as Topic ; Prevalence ; Quality of Life ; Radiotherapy ; Radiotherapy, Intensity-Modulated - adverse effects ; Radiotherapy, Intensity-Modulated - methods ; Rehabilitation Medicine ; Review Article ; Strategic planning (Business) ; Systematic review ; Trismus - etiology ; Trismus - prevention & control</subject><ispartof>Supportive care in cancer, 2010-08, Vol.18 (8), p.1033-1038</ispartof><rights>Springer-Verlag 2010</rights><rights>COPYRIGHT 2010 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-1746217b666b10304585ce2a6fd1f76e396b579e38f2763debc6554f65e72d3</citedby><cites>FETCH-LOGICAL-c503t-1746217b666b10304585ce2a6fd1f76e396b579e38f2763debc6554f65e72d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-010-0847-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-010-0847-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20213237$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bensadoun, Rene-Jean</creatorcontrib><creatorcontrib>Riesenbeck, Dorothea</creatorcontrib><creatorcontrib>Lockhart, Peter B.</creatorcontrib><creatorcontrib>Elting, Linda S.</creatorcontrib><creatorcontrib>Spijkervet, Fred K. L.</creatorcontrib><creatorcontrib>Brennan, Mike T.</creatorcontrib><creatorcontrib>Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)</creatorcontrib><title>A systematic review of trismus induced by cancer therapies in head and neck cancer patients</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><description>Purpose
This systematic review represents a thorough evaluation of the literature to clarify the impact of cancer therapies on the prevalence, quality of life and economic impact, and management strategies for cancer-therapy-induced trismus.
Methods
A systematic literature search was conducted with assistance from a research librarian in the databases MEDLINE/PubMed and EMBASE for articles published between January 1, 1990 and December 31, 2008. Each study was independently assessed by two reviewers. Taking into account predetermined quality measures, a weighted prevalence was calculated for the prevalence of trismus. The level of evidence, recommendation grade, and guideline (if possible) were given for published preventive and management strategies for trismus.
Results
We reviewed a total of 22 published studies between 1990 and 2008. Most of them assessed the prevalence of this complication, and few focused on management. The weighted prevalence for trismus was 25.4% in patients who received conventional radiotherapy and 5% for the few intensity-modulated radiation therapy studies. No clear guideline recommendations could be made for the prevention or management of trismus.
Conclusions
Newer radiation modalities may decrease the prevalence of trismus compared to conventional radiotherapy. Few studies have addressed the quality of life impact of trismus, and no studies were identified to assess the economic impact of trismus. The few preventive and management trials identified in the literature showed some promise, although larger, well-designed studies are required to appropriately assess these therapies before recommendations can be provided.</description><subject>Antimitotic agents</subject><subject>Antineoplastic agents</subject><subject>Cancer</subject><subject>Cancer patients</subject><subject>Care and treatment</subject><subject>Chemotherapy</subject><subject>Head & neck cancer</subject><subject>Head and Neck Neoplasms - therapy</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nuclear radiation</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Pain Medicine</subject><subject>Practice Guidelines as Topic</subject><subject>Prevalence</subject><subject>Quality of Life</subject><subject>Radiotherapy</subject><subject>Radiotherapy, Intensity-Modulated - adverse effects</subject><subject>Radiotherapy, Intensity-Modulated - methods</subject><subject>Rehabilitation Medicine</subject><subject>Review Article</subject><subject>Strategic planning (Business)</subject><subject>Systematic review</subject><subject>Trismus - etiology</subject><subject>Trismus - prevention & control</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kU1rFTEUhoMo9nr1B7iRoAtXU_OdmeWl-AUFF-3ORcgkJ23qncw1mancf2-GaRWl5RAO5Dzvyzm8CL2m5JQSoj8UQiQjDaH1tUI34gnaUMF5oznvnqIN6QRtBJfyBL0o5YYQqrVkz9EJI4xyxvUGfd_hciwTDHaKDme4jfALjwFPOZZhLjgmPzvwuD9iZ5ODjKdryPYQYZnha7Ae2-RxAvfjnjhUL0hTeYmeBbsv8Oqub9HFp4-XZ1-a82-fv57tzhsnCZ8aqoViVPdKqZ4SToRspQNmVfA0aAW8U73UHfA2MK24h94pKUVQEjTzfIver66HPP6coUxmiMXBfm8TjHMxWrQdV6Seu0Vv_yNvxjmnupppFelkq6iu0LsVurJ7MDGFccrWLZZmx2VLZMuEqNTpA1QtD0N0Y4IQ6_8_AroKXB5LyRDMIcfB5qOhxCxhmjVMU8M0S5hm0by523fuB_B_FPfpVYCtQKmjdAX570GPu_4GQvGmvg</recordid><startdate>20100801</startdate><enddate>20100801</enddate><creator>Bensadoun, Rene-Jean</creator><creator>Riesenbeck, Dorothea</creator><creator>Lockhart, Peter B.</creator><creator>Elting, Linda S.</creator><creator>Spijkervet, Fred K. L.</creator><creator>Brennan, Mike T.</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20100801</creationdate><title>A systematic review of trismus induced by cancer therapies in head and neck cancer patients</title><author>Bensadoun, Rene-Jean ; Riesenbeck, Dorothea ; Lockhart, Peter B. ; Elting, Linda S. ; Spijkervet, Fred K. L. ; Brennan, Mike T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-1746217b666b10304585ce2a6fd1f76e396b579e38f2763debc6554f65e72d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antimitotic agents</topic><topic>Antineoplastic agents</topic><topic>Cancer</topic><topic>Cancer patients</topic><topic>Care and treatment</topic><topic>Chemotherapy</topic><topic>Head & neck cancer</topic><topic>Head and Neck Neoplasms - therapy</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nuclear radiation</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Pain Medicine</topic><topic>Practice Guidelines as Topic</topic><topic>Prevalence</topic><topic>Quality of Life</topic><topic>Radiotherapy</topic><topic>Radiotherapy, Intensity-Modulated - adverse effects</topic><topic>Radiotherapy, Intensity-Modulated - methods</topic><topic>Rehabilitation Medicine</topic><topic>Review Article</topic><topic>Strategic planning (Business)</topic><topic>Systematic review</topic><topic>Trismus - etiology</topic><topic>Trismus - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bensadoun, Rene-Jean</creatorcontrib><creatorcontrib>Riesenbeck, Dorothea</creatorcontrib><creatorcontrib>Lockhart, Peter B.</creatorcontrib><creatorcontrib>Elting, Linda S.</creatorcontrib><creatorcontrib>Spijkervet, Fred K. L.</creatorcontrib><creatorcontrib>Brennan, Mike T.</creatorcontrib><creatorcontrib>Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bensadoun, Rene-Jean</au><au>Riesenbeck, Dorothea</au><au>Lockhart, Peter B.</au><au>Elting, Linda S.</au><au>Spijkervet, Fred K. L.</au><au>Brennan, Mike T.</au><aucorp>Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A systematic review of trismus induced by cancer therapies in head and neck cancer patients</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2010-08-01</date><risdate>2010</risdate><volume>18</volume><issue>8</issue><spage>1033</spage><epage>1038</epage><pages>1033-1038</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><abstract>Purpose
This systematic review represents a thorough evaluation of the literature to clarify the impact of cancer therapies on the prevalence, quality of life and economic impact, and management strategies for cancer-therapy-induced trismus.
Methods
A systematic literature search was conducted with assistance from a research librarian in the databases MEDLINE/PubMed and EMBASE for articles published between January 1, 1990 and December 31, 2008. Each study was independently assessed by two reviewers. Taking into account predetermined quality measures, a weighted prevalence was calculated for the prevalence of trismus. The level of evidence, recommendation grade, and guideline (if possible) were given for published preventive and management strategies for trismus.
Results
We reviewed a total of 22 published studies between 1990 and 2008. Most of them assessed the prevalence of this complication, and few focused on management. The weighted prevalence for trismus was 25.4% in patients who received conventional radiotherapy and 5% for the few intensity-modulated radiation therapy studies. No clear guideline recommendations could be made for the prevention or management of trismus.
Conclusions
Newer radiation modalities may decrease the prevalence of trismus compared to conventional radiotherapy. Few studies have addressed the quality of life impact of trismus, and no studies were identified to assess the economic impact of trismus. The few preventive and management trials identified in the literature showed some promise, although larger, well-designed studies are required to appropriately assess these therapies before recommendations can be provided.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>20213237</pmid><doi>10.1007/s00520-010-0847-4</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0941-4355 |
| ispartof | Supportive care in cancer, 2010-08, Vol.18 (8), p.1033-1038 |
| issn | 0941-4355 1433-7339 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_748936032 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Antimitotic agents Antineoplastic agents Cancer Cancer patients Care and treatment Chemotherapy Head & neck cancer Head and Neck Neoplasms - therapy Health aspects Humans Medicine Medicine & Public Health Nuclear radiation Nursing Nursing Research Oncology Pain Medicine Practice Guidelines as Topic Prevalence Quality of Life Radiotherapy Radiotherapy, Intensity-Modulated - adverse effects Radiotherapy, Intensity-Modulated - methods Rehabilitation Medicine Review Article Strategic planning (Business) Systematic review Trismus - etiology Trismus - prevention & control |
| title | A systematic review of trismus induced by cancer therapies in head and neck cancer patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T16%3A09%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20systematic%20review%20of%20trismus%20induced%20by%20cancer%20therapies%20in%20head%20and%20neck%20cancer%20patients&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Bensadoun,%20Rene-Jean&rft.aucorp=Trismus%20Section,%20Oral%20Care%20Study%20Group,%20Multinational%20Association%20for%20Supportive%20Care%20in%20Cancer%20(MASCC)/International%20Society%20of%20Oral%20Oncology%20(ISOO)&rft.date=2010-08-01&rft.volume=18&rft.issue=8&rft.spage=1033&rft.epage=1038&rft.pages=1033-1038&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-010-0847-4&rft_dat=%3Cgale_proqu%3EA358058244%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=860958617&rft_id=info:pmid/20213237&rft_galeid=A358058244&rfr_iscdi=true |